ENTITY
Nektar Therapeutics

Nektar Therapeutics (NKTR US)

8
Analysis
Health CareUnited States
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.
more
Refresh
13 Sep 2023 23:00

Status Update

Company Presentation
Share
30 Sep 2021 08:00

Corporate Presentation

Company Presentation
Share
06 Dec 2021 08:00

Investor & Analyst Call Presentation

Company Presentation
Share
No more presentations
x